IITZ-01
CAS No. 1807988-47-1
IITZ-01 ( Autophagy inhibitor IITZ-01 )
产品货号. M12762 CAS No. 1807988-47-1
IITZ-01(自噬抑制剂 IITZ-01)是一种新型强效溶酶体自噬抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥330 | 有现货 |
|
| 10MG | ¥563 | 有现货 |
|
| 25MG | ¥1070 | 有现货 |
|
| 50MG | ¥1944 | 有现货 |
|
| 100MG | ¥2763 | 有现货 |
|
| 200MG | ¥3915 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥350 | 有现货 |
|
生物学信息
-
产品名称IITZ-01
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述IITZ-01(自噬抑制剂 IITZ-01)是一种新型强效溶酶体自噬抑制剂。
-
产品描述IITZ-01 (Autophagy inhibitor IITZ-01) is a novel potent lysosomotropic autophagy inhibitor, exhibits >10-fold potent autophagy inhibition along with 12- to 20-fold better cytotoxic action than Chloroquine; enhances autophagosome accumulation but inhibit autophagosomal degradation by impairing lysosomal function, finally resulting in the inhibition of autophagy, also abolishes mitochondrial membrane potential and triggers apoptosis through the mitochondria-mediated pathway (TNBC cells IC50=1.54 uM, 48 h); displays potent antitumor action in vivo through autophagy inhibition and apoptosis induction in MDA-MB-231 breast cancer xenograft model.
-
体外实验IITZ-01 (0-2 μM, 24 h) enhances autophagosomes formation as indicated by increased expression of LC3-II levels time- and dose-dependently intriple-negative breast cancer (TNBC) cell lines (MDA-MB-231 and MDA-MB-453). IITZ-01 also demonstrates potent autophagy inhibitory activity in other breast, lung, and colon cancer cells.Western Blot Analysis Cell Line:Triple-negative breast cancer (TNBC) cell lines (MDA-MB-231 and MDA-MB-453).Concentration:0-2 μM.Incubation Time:24 hours.Result:Enhanced autophagosomes formation as indicated by increased expression of LC3-II levels.
-
体内实验IITZ-01 (45 mg/kg, i.p. every alternate day for 4 weeks) inhibits average breast tumor growth when compared with control from third day of treatment in triple-negative breast tumor models in mice. Animal Model:MDA-MB-231 (TNBC)/green fluorescent protein (GFP) orthotropic breast cancer xenografts were developed in CrTac:NCr-Foxnnu BALB/c female nude mice.Dosage:45 mg/kg.Administration:Intraperitoneal every alternate day for 4 weeks.Result:Inhibited average breast tumor growth when compared with control from third day of treatment.
-
同义词Autophagy inhibitor IITZ-01
-
通路Autophagy
-
靶点Autophagy
-
受体Autophagy
-
研究领域——
-
适应症——
化学信息
-
CAS Number1807988-47-1
-
分子量482.523
-
分子式C26H23FN8O
-
纯度>98% (HPLC)
-
溶解度DMSO : 150 mg/mL 310.87 mM; H2O : < 0.1 mg/mL
-
SMILESFC1=CC=C(NC2=NC(N3CCOCC3)=NC(NC4=CC=C(C5=NC6=CC=CC=C6N5)C=C4)=N2)C=C1
-
化学全称N2-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-N4-(4-fluorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Guntuku L, et al. Oncogene. 2018 Aug 30. doi: 10.1038/s41388-018-0446-2.
产品手册
关联产品
-
Omeprazole
奥美拉唑是一种质子泵抑制剂。
-
STO-609 acetate
STO-609 醋酸盐是 Ca2+-钙调蛋白依赖性蛋白激酶激酶的选择性、细胞渗透性抑制剂(Ki:80/15 ng/ml,对于 CaM-KKα/KKβ);竞争 ATP 结合位点。
-
sbp-7455
SBP-7455 在体外和细胞内有效抑制 ULK1/2 酶活性,降低 TNBC 细胞的活力,并在小鼠中具有口服生物利用度。
021-51111890
购物车()
sales@molnova.cn

